Inotiv, Inc..
NOTV.US | Research and experimental development on natural sciences and engineering
Inotiv, Inc. is a contract research organization (CRO) specializing in providing drug discovery and development services to the pharmaceutical, biotechnology, and chemical industries. The company offers a comprehensive suite of services, including bioanalytical testing, drug metabolism and pharmacok...Show More
Better Health for All
0
No evidence available to assess Inotiv, Inc. on Better Health for All.
Fair Money & Economic Opportunity
0
Inotiv, Inc. is a contract research organization (CRO) providing drug discovery and development services to other companies.
1
Its core business does not involve lending, insuring, moving, or storing money for consumers. Therefore, all KPIs related to consumer financial services, such as underserved client share, pricing fairness, exploitative fee exposure, inclusion initiatives, data accessibility for financial data, fair lending compliance, wealth building outcomes, financial literacy initiatives, debt burden ratio, geographic inclusion for banking services, and product simplicity for financial products, are not applicable to the company's operations.
Fair Pay & Worker Respect
-50
Inotiv's subsidiaries, Envigo Global Services, Inc. and Envigo RMS, LLC, pleaded guilty to conspiring to violate the Clean Water Act and the Animal Welfare Act, respectively.
1
These violations occurred between January 2020 and September 2022.
2
The company agreed to pay over $35 million in fines, including $22 million in criminal fines, and invest a minimum of $7 million over three years to improve facilities and personnel.
3
More than 60 violations of animal welfare laws were documented between July 2021 and March 2022, with over half deemed "direct" or "critical".
4
Fair Trade & Ethical Sourcing
0
The provided articles, including Inotiv's 2023 ESG report and ESG Framework Report, do not contain specific quantitative data or metrics related to fair trade and ethical sourcing.
1
There is no evidence regarding the percentage of tier-1 spend covered by fair-trade certifications, the frequency of supplier audits, the number of substantiated forced or child labor incidents, the traceability coverage of suppliers, the median days to close corrective action plans, the percentage of supplier contracts with enforceable ethical-sourcing clauses, the share of spend on high-risk materials, or the procurement budget directed to diverse suppliers.
2
While general commitments to ethical practices and a Global Code of Conduct are mentioned, no concrete, measurable data points for the specified KPIs are available.
3
Honest & Fair Business
0
Inotiv, Inc. was subject to an SEC investigation into possible FCPA violations related to the importation of non-human primates from Asia.
1
The investigation, which began with a voluntary request for information from the SEC on May 23, 2023, and a formal order on January 9, 2024, was closed on June 2, 2025, without enforcement action.
2
This indicates that the company incurred no ethics-related regulatory fines in the past three years. The initial voluntary request for information from the SEC suggests a degree of accountability, aligning with prompt self-reporting of minor breaches.
Kind to Animals
-60
Inotiv's core business model is fundamentally misaligned with the 'Kind to Animals' value due to its direct involvement in animal testing and breeding for research. The company was fined $35 million for Animal Welfare Act violations related to its Envigo subsidiary, which involved inhumane treatment of thousands of animals
1
. Thousands of animals, including beagles, primates, pigs, mice, and rats, are killed annually at Inotiv facilities
2
. The FDA's move away from animal testing has caused Inotiv's stock to tumble, reflecting the company's reliance on animal testing
3
,
4
. While Inotiv has an animal welfare statement committing to the 3Rs (reduction, refinement, replacement)
5
, this does not negate the inherent conflict of its business model. Approximately 10% of the portfolio carries cruelty-free seals
6
; however, this is a small portion of the overall business. Given the materiality of animal testing to Inotiv's revenue and the documented animal welfare violations, a strong negative score is warranted. The company's code of conduct mentions animal welfare but lacks specific metrics
7
.
No War, No Weapons
0
Inotiv's core business is drug discovery and development services. While the company states it implements and enforces processes and controls to ensure modern slavery is not taking place in its business or supply chain, and commits to complying with U.S. anti-bribery, sanctions, and export control regulations,
1
the provided articles do not contain specific, quantifiable data points for any of the KPIs related to the 'No War, No Weapons' value. There is no information on revenue from arms contracts, dual-use technology R&D, sales to embargoed regimes, peacebuilding investment as a proportion of revenue, or the existence and outcomes of specific policies and audits related to conflict exposure, human rights due diligence in conflict areas, or ethical red lines. Therefore, no KPIs can be scored based on the provided evidence.
Planet-Friendly Business
-80
The company's subsidiary, Envigo Global Services Inc., pleaded guilty to a felony of conspiring to knowingly violate the Clean Water Act, resulting in an $11 million fine.
1
The wastewater treatment plant at its Cumberland facility had issues with exceeding effluent limits, unauthorized discharges, and unsanitary conditions.
2
Inotiv is paying $3.5 million to the National Fish and Wildlife Foundation for environmental projects in Cumberland County, Virginia, with at least $500,000 allocated for purchasing riparian wetland or land.
3
The company is under SEC investigation for potential FCPA violations related to the illegal importation of macaques, with employees of its main supplier and Cambodian government officials prosecuted for illegally importing endangered long-tailed macaques.
4
Inotiv is working to understand the implications of the Task Force on Climate-Related Financial Disclosures (TCFD) and is working on climate scenario modeling and risk management.
5
The company is building internal knowledge regarding GHG emissions and working to define inventory boundaries for scopes 1, 2, and 3 emissions, but has not yet quantified improvements.
6
Inotiv is also working to understand the implications of the Science-Based Targets Initiative (SBTi).
7
The company has made a $5 million investment in water treatment and management at one facility and is implementing more efficient water use throughout cleaning cycles, including reusing final rinse water for pre-rinse cycles and greywater for non-potable purposes, and installing low-flow fixtures.
8
The company is recycling and composting on-site to divert waste from landfill and incinerators.
9
Inotiv has taken steps to reduce scope 1 and scope 2 GHG emissions, including consolidating operating facilities, optimizing its distribution network, upgrading its fleet to more fuel-efficient models, and upgrading aging plants with increased energy-efficiency models.
10
Respect for Cultures & Communities
0
No specific, concrete evidence was found in the provided articles regarding Inotiv, Inc.'s performance on any of the KPIs related to Respect for Cultures & Communities. The articles either discuss unrelated topics, are inaccessible, or explicitly state that no data on community engagement, cultural impact, local employment, grievance mechanisms, or other relevant social responsibility factors is present.
1
Safe & Smart Tech
0
No evidence available to assess Inotiv, Inc. on Safe & Smart Tech.
Zero Waste & Sustainable Products
0
No evidence available to assess Inotiv, Inc. on Zero Waste & Sustainable Products.